Evidence On Viral Suppression Supports Scaling-Up Transition To Dolutegravir-Based Regimens In Pediatric Populations In Cameroon: A Multicentre Baseline Assessment For The Cipher-Adola Study

• DOI: 10.20944/preprints202407.0512.v1
• Publication Date: 2024-07-09T06:39:07Z
• Authors: Joseph FOKAM; Yagai Bouba; Rogers Awoh Ajeh; Dominik Tameza Gu...; Suzane Essamba; Albert Franck Zeh...; Ebiama Lifanda; Rose Armelle Ada; Yakouba Liman; Nancy Barbara Mbe...; Audrey Raissa Dza...; Suzie Ndiang Tetang; Samuel Martin Sosso; Jocelyne Carmen B...; Olivia Francette ...; Edith Michele Tem...; Caroline Medouane; Sabine Ndejo Atsi...; Justin Leonel Mvogo; Roger Martin Onana; Jean de Dieu Anou...; Alice Ketchaji; Alex Durand Nka; Davy-Hyacinthe An...; Aude Christelle Ka’e; Nadine Nguendjoun...; Rachel Simo Kamgaing; Désiré Augustin K...; Michel Carlos Tom...; Ezechiel Ngoufack...; Marie Atsama Amougou; Julius Nwobegahay; Comfort Vuchas; Anna Nya Nsimen; Bertrand Bille Eyoum; Sandra kenmegne G...; Francis Ndongo Ateba; Daniel Kesseng; Serge Clotaire Bi...; Daniele Armenia; Maria Mercedes Sa...; Francesca Ceccher...; Paul Ndombo Koki; Hadja Cherif Hams...; Vittorio Colizzi; Alexis Ndjolo; Carlo Federico Perno; Anne-Cécile Zoung...
• Keywords: Dolutegravir

Mortality in children accounts for 15% of all AIDS-related deaths globally, with a higher burden among Cameroonian (25%), likely due to poor virological response. We sought evaluate viral suppression (VS) and its determinants nationally representative paediatric young adult population receiving antiretroviral therapy (ART). A cross-sectional multicentric study was conducted (